Imbria Pharmaceuticals
PrivateLast Round
Series B
Nov 17, 2025
Est. Valuation
$189.2M
Total Funding Raised
$231.7M
Company Overview
Imbria Pharmaceuticals is a biotechnology company dedicated to developing innovative therapies aimed at restoring cellular energy production in patients with cardiometabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imbria Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Imbria Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 17, 2025 | ||||
| Series B | Apr 10, 2025 | ||||
| Series A | Jun 18, 2020 |
Key People
Founding team and executive leadership
Imbria Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B |
| SV Health Investors | Series B |
| AXA IM Alts | Series B |
| Deep Track Capital | Series B |
| Catalio Capital Management | Series B |
| AN Venture Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 16, 2025
Partnered with the Hypertrophic Cardiomyopathy Association (HCMA).
- Aug 19, 2025
Albert M. Kim appointed to lead clinical development.
Imbria Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Imbria Pharmaceuticals's valuation, stock price, and market status.
